Cargando…

RNA-Based Strategies for Cell Reprogramming toward Pluripotency

Cell therapy approaches to treat a wide range of pathologies have greatly benefited from cell reprogramming techniques that allow the conversion of a somatic cell into a pluripotent cell. Many technological developments have been made since the initial major discovery of this biological process. Rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailly, Anaëlle, Milhavet, Ollivier, Lemaitre, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876983/
https://www.ncbi.nlm.nih.gov/pubmed/35214051
http://dx.doi.org/10.3390/pharmaceutics14020317
_version_ 1784658298852605952
author Bailly, Anaëlle
Milhavet, Ollivier
Lemaitre, Jean-Marc
author_facet Bailly, Anaëlle
Milhavet, Ollivier
Lemaitre, Jean-Marc
author_sort Bailly, Anaëlle
collection PubMed
description Cell therapy approaches to treat a wide range of pathologies have greatly benefited from cell reprogramming techniques that allow the conversion of a somatic cell into a pluripotent cell. Many technological developments have been made since the initial major discovery of this biological process. Recently reprogramming methods based on the use of RNA have emerged and seem very promising. Thus, in this review we will focus on presenting the interest of such methods for cell reprogramming but also how these RNA-based strategies can be extended to eventually lead to medical applications to improve healthspan and longevity.
format Online
Article
Text
id pubmed-8876983
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88769832022-02-26 RNA-Based Strategies for Cell Reprogramming toward Pluripotency Bailly, Anaëlle Milhavet, Ollivier Lemaitre, Jean-Marc Pharmaceutics Review Cell therapy approaches to treat a wide range of pathologies have greatly benefited from cell reprogramming techniques that allow the conversion of a somatic cell into a pluripotent cell. Many technological developments have been made since the initial major discovery of this biological process. Recently reprogramming methods based on the use of RNA have emerged and seem very promising. Thus, in this review we will focus on presenting the interest of such methods for cell reprogramming but also how these RNA-based strategies can be extended to eventually lead to medical applications to improve healthspan and longevity. MDPI 2022-01-28 /pmc/articles/PMC8876983/ /pubmed/35214051 http://dx.doi.org/10.3390/pharmaceutics14020317 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Bailly, Anaëlle
Milhavet, Ollivier
Lemaitre, Jean-Marc
RNA-Based Strategies for Cell Reprogramming toward Pluripotency
title RNA-Based Strategies for Cell Reprogramming toward Pluripotency
title_full RNA-Based Strategies for Cell Reprogramming toward Pluripotency
title_fullStr RNA-Based Strategies for Cell Reprogramming toward Pluripotency
title_full_unstemmed RNA-Based Strategies for Cell Reprogramming toward Pluripotency
title_short RNA-Based Strategies for Cell Reprogramming toward Pluripotency
title_sort rna-based strategies for cell reprogramming toward pluripotency
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876983/
https://www.ncbi.nlm.nih.gov/pubmed/35214051
http://dx.doi.org/10.3390/pharmaceutics14020317
work_keys_str_mv AT baillyanaelle rnabasedstrategiesforcellreprogrammingtowardpluripotency
AT milhavetollivier rnabasedstrategiesforcellreprogrammingtowardpluripotency
AT lemaitrejeanmarc rnabasedstrategiesforcellreprogrammingtowardpluripotency